fda compounding glp-1 crackdown news today New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA GLP-1 Compounding Crackdown

Wegovy Treatment Millions of Americans, including those in Kingston, New York, grapple with obesitya condition that significantly impacts both physical health and mental well-being

In theory, 1 g of edetate calcium can theoretically bind 620 mg of lead, but in reality only about 5 mg per gram is actually excreted into the urine in lead poisoned patients

Histamine Storage and Release

June 2026 Update: OROS has begun rolling out USP Residual Solvent Analysis on all newly manufactured batches, screening for trace residual solvents including Acetonitrile, Methanol, DMF, and Dichloromethane as part of our continued commitment to comprehensive batch-level quality control